Cartalax | 20mg | Cartilage-Targeted Regulatory Peptide
For In Vitro Research Use Only — Not for Human or Veterinary Use

Description:
Cartalax is a synthetic short-chain peptide derived from natural cartilage tissue sequences, studied for its potential role in regulating cellular processes associated with cartilage integrity, joint health, and connective tissue metabolism.

In vitro studies have explored Cartalax for its involvement in supporting chondrocyte function, collagen synthesis, and extracellular matrix maintenance. It is of particular interest in experimental models focused on cartilage regeneration and cellular signaling related to structural tissue repair.

This vial contains 20mg of lyophilized Cartalax peptide, intended for advanced biochemical and in vitro research applications.

---

Specifications:

• Unit Size: 20mg (lyophilized powder, single vial)

• Form: Crystalline lyophilized peptide

• Molecular Weight: ~879 Da

• Sequence: Glu-Asp-Gly

---

Application Context:
Cartalax is studied in vitro for its potential roles in:

• Cellular signaling related to cartilage and connective tissue regeneration

• Chondrocyte metabolism and protein synthesis

• Collagen and extracellular matrix synthesis support

• Inflammation and oxidative stress response modulation

---

Intended Use:
This compound is intended strictly for in vitro laboratory research. It is not approved for human or animal administration and must not be used in food, dietary supplements, cosmetics, or pharmaceuticals.

---

Legal Disclaimer:
This product and related information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, cure, or prevention of any disease. Use is restricted to qualified research professionals in certified laboratory environments.

---

Terms of Sale:
By purchasing from Mile High Compounds, the buyer affirms they are a qualified researcher or institution, fully responsible for lawful handling, storage, and research use of this material. All sales are final.